Revolutionizing Adoptive Cell Therapy Development with Bruker’s Beacon® Platform

All Resources

App Note

Bruker’s optofluidic Beacon technology provides deterministic control over individual cells to perform thousands of experiments with single cells in parallel for unique and powerful insights into cellular functionality.

First Name*

Last Name*

Email*

Company Name*

Country*

Application Area*

Research Area*

By submitting this form, I confirm that I would like to receive information from Bruker Cellular Analysis and I agree to the Website Privacy Policy and Terms of Conditions.*

What's Inside

In this App Note we discuss:

Adoptive Cell Therapy Development Challenges and Opportunities

Advanced Single-Cell Functional Characterization with the Beacon Platform

The Adoptive Cell Therapy Development Timeline

Get the App Note

Back to the Top